The role of the novel D2/$beta;2-agonist, Viozan? (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation
Year: 2003
Type: article
Study design: Clinical Trial
Source: Respiratory Medicine
Authors: L LAURSEN, A Lindqvist, T Hepburn, J Lloyd, J Perrett, N Sanders, K Rocchiccioli
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4256598768
